A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

The cancer drug leucovorin has been in high demand since the Trump administration endorsed it as a treatment for some autistic kids. Some experts say the drug's popularity has outpaced the science.

Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

By Elizabeth Chapin University of Kentucky The University of Kentucky Markey Cancer Center has treated the first patient in ...

The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades ...

Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer ...

Ibuprofen’s anti-inflammatory action may influence cancer risk, but evidence remains complex and routine use for prevention is not advised. Ibuprofen is one of the most widely used pain relievers, ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...

In a presentation, executives discussed upcoming data readouts and their potential effect on reimbursement for the firm's FirstLook Lung test.

ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...